EP 1658094 A1 20060524 - C1-INH AS A DRUG FOR TREATING VIRUSES PATHOGENIC TO HUMANS
Title (en)
C1-INH AS A DRUG FOR TREATING VIRUSES PATHOGENIC TO HUMANS
Title (de)
C1-INH ALS ARZNEIMITTEL ZUR BEHANDLUNG VON FÜR DEN MENSCHEN PATHOGENEN VIREN
Title (fr)
UTILISATION DE C1-INH EN TRAITEMENT DE VIRUS PATHOGENES POUR L'HOMME
Publication
Application
Priority
- EP 2004009085 W 20040813
- DE 10338533 A 20030819
- DE 10355408 A 20031125
Abstract (en)
[origin: WO2005016375A1] The C1 esterase inhibitor (C1-INH) from human plasma is a sialic-acid-containing glycoprotein which can bind other glycoproteins and glycolipids which may be components or even membrane components of microoganisms of viral and bacterial origin. In accordance with the invention, this binding can inhibit the penetration of certain viruses into target cells.
IPC 1-7
IPC 8 full level
A61K 38/57 (2006.01); A61P 31/12 (2006.01); A61P 31/16 (2006.01); C12Q 1/04 (2006.01); C12Q 1/44 (2006.01)
CPC (source: EP)
A61K 38/57 (2013.01); A61P 31/12 (2017.12); A61P 31/16 (2017.12); C12Q 1/04 (2013.01); C12Q 1/44 (2013.01)
Citation (search report)
See references of WO 2005016375A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2005016375 A1 20050224; AU 2004264673 A1 20050224; CA 2535984 A1 20050224; EP 1658094 A1 20060524
DOCDB simple family (application)
EP 2004009085 W 20040813; AU 2004264673 A 20040813; CA 2535984 A 20040813; EP 04764082 A 20040813